Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shertech Laboratories was a specialized radiopharmaceutical company based in Greer, South Carolina, that focused on the compounding and distribution of nuclear medicine. The company provided a range of radiopharmaceutical products used primarily for diagnostic imaging and therapeutic applications in oncology, cardiology, and neurology. In 2017, Shertech was acquired by Jubilant Pharma, a global pharmaceutical company, as part of an effort to expand its radiopharmacy footprint in the United States. Following the acquisition, Shertech's operations were integrated into the Jubilant Radiopharma business unit. The company played a significant role in the regional supply chain for critical medical isotopes in the Southeastern United States. Its facilities were designed to meet stringent regulatory standards for the handling and preparation of radioactive materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shertech Laboratories.